Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Signal Transduction and Targeted Therapy|July 27, 2022
SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl<sup>-</sup> accumulation in respiratory epitheliumLei Chen, Wei-Jie Guan, Zhuo-Er Qiu, et al.
The Journal of Infection|November 5, 2022
Toxoplasma gondii infection triggers ongoing inflammation mediated by increased intracellular Cl<sup>-</sup> concentration in airway epitheliumZhuo-Er Qiu, Lei Chen, Xiao-Chun Hou, et al.
The Journal of Clinical Investigation|April 29, 2025
A gain-of-function mutation in ATP6V0A4 drives primary distal renal tubular alkalosis with enhanced V-ATPase activitySi-Qi Peng, Qian-Qian Wu, Wan-Yi Wang, et al.
Mucosal Immunology|March 17, 2018
Increased intracellular Cl<sup>-</sup> concentration promotes ongoing inflammation in airway epitheliumYi-Lin Zhang, Peng-Xiao Chen, Wei-Jie Guan, et al.
Journal of Medical Case Reports|December 10, 2022
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case reportBai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, et al.
Biochemical and Biophysical Research Communications|April 17, 2017
Role of GPR30 in estrogen-induced prostate epithelial apoptosis and benign prostatic hyperplasiaDeng-Liang Yang, Jia-Wen Xu, Jian-Guo Zhu, et al.
Nature Communications|April 28, 2026
Uromodulin p.His36Tyr promotes macrophage pyroptosis via App-Cd74 signaling to drive renal inflammation in ADTKDQian-Qian Wu, Si-Qi Peng, Yi-Lin Zhang, et al.
Journal of Hematology & Oncology|December 22, 2018
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myelomaWan-Hong Zhao, Jie Liu, Bai-Yan Wang, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Pageof 11